Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rubén Corpas

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|June 4, 2020
Pharmacological Inhibition of Soluble Epoxide Hydrolase as a New Therapy for Alzheimer's DiseaseChristian Griñán-Ferré, Sandra Codony, Eugènia Pujol, et al.
Scientific Reports|September 6, 2017
HIV-1 matrix protein p17 misfolding forms toxic amyloidogenic assemblies that induce neurocognitive disordersYasmin Zeinolabediny, Francesca Caccuri, Laura Colombo, et al.
Journal of Medicinal Chemistry|May 4, 2021
From the Design to the <i>In Vivo</i> Evaluation of Benzohomoadamantane-Derived Soluble Epoxide Hydrolase Inhibitors for the Treatment of Acute PancreatitisSandra Codony, Carla Calvó-Tusell, Elena Valverde, et al.
Journal of Medicinal Chemistry|October 12, 2022
Synthesis, In Vitro Profiling, and In Vivo Evaluation of Benzohomoadamantane-Based Ureas for Visceral Pain: A New Indication for Soluble Epoxide Hydrolase InhibitorsSandra Codony, José M Entrena, Carla Calvó-Tusell, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|October 23, 2025
Dimethoxybenzohomoadamantane-based soluble epoxide hydrolase inhibitors: <i>in vivo</i> efficacy in a murine model of chemotherapy-induced neuropathic painSandra Codony, Beatrice Jora, Miriam Santos-Caballero, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|June 4, 2020
Pharmacological Inhibition of Soluble Epoxide Hydrolase as a New Therapy for Alzheimer's DiseaseChristian Griñán-Ferré, Sandra Codony, Eugènia Pujol, et al.
Scientific Reports|September 6, 2017
HIV-1 matrix protein p17 misfolding forms toxic amyloidogenic assemblies that induce neurocognitive disordersYasmin Zeinolabediny, Francesca Caccuri, Laura Colombo, et al.
Journal of Medicinal Chemistry|May 4, 2021
From the Design to the <i>In Vivo</i> Evaluation of Benzohomoadamantane-Derived Soluble Epoxide Hydrolase Inhibitors for the Treatment of Acute PancreatitisSandra Codony, Carla Calvó-Tusell, Elena Valverde, et al.
Journal of Medicinal Chemistry|October 12, 2022
Synthesis, In Vitro Profiling, and In Vivo Evaluation of Benzohomoadamantane-Based Ureas for Visceral Pain: A New Indication for Soluble Epoxide Hydrolase InhibitorsSandra Codony, José M Entrena, Carla Calvó-Tusell, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|October 23, 2025
Dimethoxybenzohomoadamantane-based soluble epoxide hydrolase inhibitors: <i>in vivo</i> efficacy in a murine model of chemotherapy-induced neuropathic painSandra Codony, Beatrice Jora, Miriam Santos-Caballero, et al.
Pageof 3